A.R.T. Advisors, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2019$87,000
-17.9%
27,591
-24.2%
0.01%
-28.6%
Q4 2018$106,000
-70.1%
36,391
-73.0%
0.01%
-56.2%
Q3 2018$354,000
-19.7%
134,710
-10.3%
0.02%
-11.1%
Q1 2018$441,000
+359.4%
150,099
+283.8%
0.02%
+260.0%
Q2 2017$96,000
-88.6%
39,109
-89.5%
0.01%
-87.2%
Q1 2017$842,000
+144.1%
371,000
+127.7%
0.04%
+85.7%
Q4 2016$345,000
-74.6%
162,900
-62.3%
0.02%
-69.1%
Q2 2016$1,356,000
-49.8%
432,031
-46.8%
0.07%
-43.8%
Q1 2016$2,703,000
+25.8%
812,008
+33.7%
0.12%
+18.6%
Q4 2015$2,149,000
+328.9%
607,308
+509.4%
0.10%
+436.8%
Q3 2015$501,000
-77.9%
99,661
-71.7%
0.02%
-75.0%
Q2 2015$2,267,000
+209.7%
352,672
+238.8%
0.08%
+204.0%
Q1 2015$732,000
-63.5%
104,093
-60.0%
0.02%
-66.7%
Q4 2014$2,006,000
+57.2%
260,262
+52.3%
0.08%
+27.1%
Q3 2014$1,276,000
-11.9%
170,879
-6.0%
0.06%
-25.3%
Q3 2013$1,448,000181,7690.08%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders